Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09OTM
|
|||
| Former ID |
DIB020893
|
|||
| Drug Name |
s-allylglycine
|
|||
| Synonyms |
L-Allylglycine; 16338-48-0; (S)-2-aminopent-4-enoic acid; H-Gly(Ally)-OH; (2S)-2-aminopent-4-enoic acid; (S)-(-)-2-Amino-4-pentenoic acid; (S)-2-Amino-4-pentenoic acid; L-alpha-Allyl-Gly; L-2-Amino-4-pentenoic acid; (S)-2-Amino-4- Pentenoic Acid; (S)-ALLYLGLYCINE; 3-VINYL-L-ALANINE; 4-Pentenoic acid, 2-amino-, (2S)-; (2S)-2-amino-4-pentenoic acid; (S)-2-Amino-pent-4-enoic acid; MFCD00002627; s-allylglycine; D-Allylglycine hydrochloride; (-)-Allylglycine; H-Gly(allyl)-OH; (S)-(-)-alpha-Allylglycine, 98%, 98% ee; C5H9NO2
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C5H9NO2
|
|||
| Canonical SMILES |
C=CCC(C(=O)O)N
|
|||
| InChI |
1S/C5H9NO2/c1-2-3-4(6)5(7)8/h2,4H,1,3,6H2,(H,7,8)/t4-/m0/s1
|
|||
| InChIKey |
WNNNWFKQCKFSDK-BYPYZUCNSA-N
|
|||
| CAS Number |
CAS 16338-48-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
3140872, 10256489, 11110777, 16044030, 17404704, 24278237, 24845889, 24856862, 29199668, 46241016, 48020062, 48437419, 50105874, 50105875, 53777247, 57351246, 74584389, 81051986, 87358047, 90340783, 92303441, 92716721, 96026544, 99298799, 104246070, 113460899, 117518248, 117681122, 121361048, 124749482, 126574696, 126622731, 126662729, 126670592, 126682910, 126733253, 129607131, 132622477, 135123113, 135692853, 135696504, 136380292, 142416174, 143396704, 151993409, 160810477, 162042254, 162474579, 163564095, 164032796
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glutamate decarboxylase 2 (GAD2) | Target Info | Inhibitor | [2] |
| Glutamic acid decarboxylase 1 (GAD1) | Target Info | Inhibitor | [3] | |
| BioCyc | Glutamate dependent acid resistance | |||
| GABA shunt | ||||
| KEGG Pathway | Alanine, aspartate and glutamate metabolism | |||
| beta-Alanine metabolism | ||||
| Taurine and hypotaurine metabolism | ||||
| Butanoate metabolism | ||||
| Metabolic pathways | ||||
| GABAergic synapse | ||||
| Type I diabetes mellitus | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| Panther Pathway | Gamma-aminobutyric acid synthesis | |||
| WikiPathways | Biogenic Amine Synthesis | |||
| GABA synthesis, release, reuptake and degradation | ||||
| Alanine and aspartate metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5267). | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1273). | |||
| REF 3 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1272). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.